GB1309692A
(en)
*
|
1970-02-13 |
1973-03-14 |
Ucb Sa |
N-substituted lactams
|
FR2059985A1
(en)
*
|
1969-08-29 |
1971-06-11 |
Synthelabo |
4-benzyl piperidine 2,6-dione derivs
|
US4081456A
(en)
*
|
1973-02-28 |
1978-03-28 |
Mobil Oil Corporation |
Bis-lactam derivatives
|
IT1045043B
(it)
*
|
1975-08-13 |
1980-04-21 |
Isf Spa |
Derivati pirrolidinici
|
AT360980B
(de)
*
|
1976-01-14 |
1981-02-10 |
Pliva Pharm & Chem Works |
Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins
|
US4069336A
(en)
*
|
1976-02-25 |
1978-01-17 |
Chemisches Laboratorium Fritz-Walter Lange Gmbh & Co Kg |
(2-oxo-pyrrolidines)-acetic hydrazides
|
GB1583871A
(en)
|
1976-10-19 |
1981-02-04 |
Ucb Sa |
Anti-aggregants
|
GB1539817A
(en)
*
|
1976-10-22 |
1979-02-07 |
Ucb Sa |
N-substituted lactams
|
GB1582351A
(en)
*
|
1977-02-10 |
1981-01-07 |
Ucb Sa |
Disubstituted ureas and thioureas
|
DE2757680A1
(de)
*
|
1977-12-23 |
1979-06-28 |
Troponwerke Gmbh & Co Kg |
Neue 2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
CA1115212A
(en)
|
1978-02-10 |
1981-12-29 |
Emilio Kyburz |
Pyrrolidine derivatives
|
EP0005689B1
(fr)
|
1978-05-08 |
1981-03-18 |
U C B, S.A. |
Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
|
IT1141287B
(it)
*
|
1979-06-13 |
1986-10-01 |
Nattermann A & Cie |
Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
|
DE2924011C2
(de)
|
1979-06-13 |
1982-04-08 |
A. Nattermann & Cie GmbH, 5000 Köln |
Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
|
FR2515179A1
(fr)
*
|
1981-07-24 |
1983-04-29 |
Hoffmann La Roche |
Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
|
DE3361609D1
(en)
*
|
1982-03-24 |
1986-02-06 |
Prodes Sa |
New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
|
US4525476A
(en)
*
|
1983-05-26 |
1985-06-25 |
Warner-Lambert Company |
N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
|
DE3326724A1
(de)
*
|
1983-07-25 |
1985-02-07 |
Boehringer Ingelheim KG, 6507 Ingelheim |
In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
|
DE3336024A1
(de)
*
|
1983-10-04 |
1985-04-18 |
Boehringer Ingelheim KG, 6507 Ingelheim |
4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
|
DE3420193A1
(de)
*
|
1984-05-30 |
1985-12-05 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
|
FI83510C
(fi)
*
|
1985-02-22 |
1991-07-25 |
Ciba Geigy Ag |
Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara bi-2h- pyrroli(di)ndioner.
|
PH23078A
(en)
*
|
1986-01-30 |
1989-04-10 |
Ciba Geigy Ag |
Substituted pyrrolidinones
|
IT1224168B
(it)
*
|
1986-08-01 |
1990-09-26 |
Finanziaria R F Spa Ora Finanz |
Derivati del pirrolidin-2-one ad attivita' nootropa
|
US4990513A
(en)
*
|
1987-02-06 |
1991-02-05 |
S O "Pharmachim" |
Antihypoxic drug and method of its application
|
WO1988009330A1
(en)
*
|
1987-05-20 |
1988-12-01 |
Zambon Group S.P.A. |
Isoxazoles with nootropic activity
|
JPS6422883A
(en)
*
|
1987-07-17 |
1989-01-25 |
Sanwa Kagaku Kenkyusho Co |
1-pyrrolidine acetamide derivative, its salt, production thereof and prophylactic and remedial agent for cereral dysfunction containing said derivative and salt as active ingredient
|
JP2660201B2
(ja)
*
|
1988-08-05 |
1997-10-08 |
塩野義製薬株式会社 |
新規ピロロ[1,4]ベンゾジアゼピン誘導体および老人性痴呆薬
|
JPH0665197A
(ja)
*
|
1992-06-19 |
1994-03-08 |
Dai Ichi Seiyaku Co Ltd |
ピロリジニルアセトアミド誘導体の製法
|
CN1041630C
(zh)
*
|
1994-01-13 |
1999-01-13 |
北京大学 |
合成α-吡咯烷酮乙酰胺的方法
|
US5912189A
(en)
*
|
1998-05-12 |
1999-06-15 |
The Lubrizol Corporation |
Compositions containing reaction product of a cyclic compound containing both a nitrogen atom and a carbonyl group, an aldehyde or ketone, and an etheramine
|
GB0004297D0
(en)
|
2000-02-23 |
2000-04-12 |
Ucb Sa |
2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
|
WO2002053153A1
(fr)
*
|
2000-12-28 |
2002-07-11 |
Daiichi Pharmaceutical Co., Ltd. |
Medicaments permettant de traiter et de prevenir une douleur neurologique
|
JP5677856B2
(ja)
|
2008-02-29 |
2015-02-25 |
バイオラブ・サヌス・ファーマセウティカ・エルティーディーエー. |
医薬組成物
|
EA033130B1
(ru)
|
2008-10-16 |
2019-08-30 |
Дзе Джонс Хопкинс Юниверсити |
Способы и композиции для улучшения когнитивной функции
|
PL389364A1
(pl)
|
2009-10-23 |
2011-04-26 |
Uniwersytet Jagielloński |
Nowe zastosowanie pochodnych 2-pirolidonu
|
US20110212928A1
(en)
|
2010-02-09 |
2011-09-01 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
EP2919788A4
(en)
|
2012-11-14 |
2016-05-25 |
Univ Johns Hopkins |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
|
US10806717B2
(en)
|
2013-03-15 |
2020-10-20 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
ES2881081T3
(es)
|
2013-03-15 |
2021-11-26 |
Agenebio Inc |
Procedimientos y composiciones para mejorar la función cognitiva
|
KR20200036063A
(ko)
|
2014-01-21 |
2020-04-06 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
JP6629740B2
(ja)
|
2014-01-21 |
2020-01-15 |
ヤンセン ファーマシューティカ エヌ.ベー. |
代謝型グルタミン酸作動性受容体サブタイプ2の正のアロステリック調節因子またはオルトステリックアゴニストを含む組み合わせ、およびそれらの使用
|
KR102296653B1
(ko)
|
2016-12-16 |
2021-09-01 |
이도르시아 파마슈티컬스 리미티드 |
T-유형 칼슘 채널 차단제를 포함하는 약학 조합물
|
EA037205B1
(ru)
*
|
2019-05-20 |
2021-02-19 |
Дмитрий Сергеевич Валуев |
Способ получения 2-(2-оксопирролидин-1-ил)-n-фенилацетамида
|
US20240132513A1
(en)
|
2022-08-19 |
2024-04-25 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|